Literature DB >> 19025115

Interaction between the coagulation and complement system.

Umme Amara1, Daniel Rittirsch, Michael Flierl, Uwe Bruckner, Andreas Klos, Florian Gebhard, John D Lambris, Markus Huber-Lang.   

Abstract

The complement system as a main column of innate immunity and the coagulation system as a main column in hemostasis undergo massive activation early after injury. Interactions between the two cascades have often been proposed but the precise molecular pathways of this interplay are still in the dark. To elucidate the mechanisms involved, the effects of various coagulation factors on complement activation and generation of anaphylatoxins were investigated and summarized in the light of the latest literature. Own in vitro findings suggest, that the coagulation factors FXa, FXIa and plasmin may cleave both C5 and C3, and robustly generate C5a and C3a (as detected by immunoblotting and ELISA). The produced anaphylatoxins were found to be biologically active as shown by a dose-dependent chemotactic response of neutrophils and HMC-1 cells, respectively. Thrombin did not only cleave C5 (Huber-Lang et al. 2006) but also in vitro-generated C3a when incubated with native C3. The plasmin-induced cleavage activity could be dose-dependently blocked by the serine protease inhibitor aprotinin and leupeptine. These findings suggest that various serine proteases belonging to the coagulation system are able to activate the complement cascade independently of the established pathways. Moreover, functional C5a and C3a are generated, both of which are known to be crucially involved in the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19025115      PMCID: PMC2713875          DOI: 10.1007/978-0-387-78952-1_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  22 in total

1.  Complement activation mediates intestinal injury after resuscitation from hemorrhagic shock.

Authors:  D A Spain; T M Fruchterman; P J Matheson; M A Wilson; A W Martin; R N Garrison
Journal:  J Trauma       Date:  1999-02

2.  The relationship between inflammation and the coagulation system.

Authors:  Goda Choi; Marcus J Schultz; Marcel Levi; Tom van der Poll
Journal:  Swiss Med Wkly       Date:  2006-03-04       Impact factor: 2.193

3.  Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock.

Authors:  P M Jansen; B Eisele; I W de Jong; A Chang; U Delvos; F B Taylor; C E Hack
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

4.  [Blood coagulation parameters as prognostic factors in multiple trauma: can clinical values be an early diagnostic aid?].

Authors:  L Lampl; M Helm; A Specht; K H Bock; W Hartel; E Seifried
Journal:  Zentralbl Chir       Date:  1994       Impact factor: 0.942

5.  A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways.

Authors:  Konstantinos Ritis; Michael Doumas; Dimitrios Mastellos; Anastasia Micheli; Stavros Giaglis; Paola Magotti; Stavros Rafail; Georgios Kartalis; Paschalis Sideras; John D Lambris
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

6.  C5a induces tissue factor activity on endothelial cells.

Authors:  K Ikeda; K Nagasawa; T Horiuchi; T Tsuru; H Nishizaka; Y Niho
Journal:  Thromb Haemost       Date:  1997-02       Impact factor: 5.249

7.  Generation of C5a in the absence of C3: a new complement activation pathway.

Authors:  Markus Huber-Lang; J Vidya Sarma; Firas S Zetoune; Daniel Rittirsch; Thomas A Neff; Stephanie R McGuire; John D Lambris; Roscoe L Warner; Michael A Flierl; Laszlo M Hoesel; Florian Gebhard; John G Younger; Scott M Drouin; Rick A Wetsel; Peter A Ward
Journal:  Nat Med       Date:  2006-05-21       Impact factor: 53.440

Review 8.  New aspects in thrombotic research: complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotype.

Authors:  Johann Wojta; Kurt Huber; Peter Valent
Journal:  Pathophysiol Haemost Thromb       Date:  2003 Sep-2004 Dec

9.  Detrimental effects of complement activation in hemorrhagic shock.

Authors:  J G Younger; N Sasaki; M D Waite; H N Murray; E F Saleh; Z B Ravage; R B Hirschl; P A Ward; G O Till; Z A Ravage
Journal:  J Appl Physiol (1985)       Date:  2001-02

10.  Complement inhibition prevents gut ischemia and endothelial cell dysfunction after hemorrhage/resuscitation.

Authors:  T M Fruchterman; D A Spain; M A Wilson; P D Harris; R N Garrison
Journal:  Surgery       Date:  1998-10       Impact factor: 3.982

View more
  138 in total

1.  Morphological and functional characterization of leech circulating blood cells: role in immunity and neural repair.

Authors:  Céline Boidin-Wichlacz; David Vergote; Christian Slomianny; Nathalie Jouy; Michel Salzet; Aurélie Tasiemski
Journal:  Cell Mol Life Sci       Date:  2011-12-11       Impact factor: 9.261

2.  Plasminogen is a complement inhibitor.

Authors:  Diana Barthel; Susann Schindler; Peter F Zipfel
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

3.  Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.

Authors:  Beatrix Schäfer; Adrian M Piliponsky; Tatsuya Oka; Chang Ho Song; Norma P Gerard; Craig Gerard; Mindy Tsai; Janet Kalesnikoff; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2012-06-22       Impact factor: 10.793

Review 4.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

5.  Hypocomplementemia associated with macrophage activation syndrome in systemic juvenile idiopathic arthritis and adult onset still's disease: 3 cases.

Authors:  Mark Gorelik; Kathryn S Torok; Daniel A Kietz; Raphael Hirsch
Journal:  J Rheumatol       Date:  2011-02       Impact factor: 4.666

Review 6.  Coagulation abnormalities in the trauma patient: the role of point-of-care thromboelastography.

Authors:  Eduardo Gonzalez; Fredric M Pieracci; Ernest E Moore; Jeffry L Kashuk
Journal:  Semin Thromb Hemost       Date:  2010-10-26       Impact factor: 4.180

Review 7.  The complement cascade as a therapeutic target in intracerebral hemorrhage.

Authors:  Andrew F Ducruet; Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Mason L Yeh; Sergey A Sosunov; E Sander Connolly
Journal:  Exp Neurol       Date:  2009-07-24       Impact factor: 5.330

8.  Complement component 3 is necessary to preserve myocardium and myocardial function in chronic myocardial infarction.

Authors:  Marcin Wysoczynski; Mitesh Solanki; Sylwia Borkowska; Patrick van Hoose; Kenneth R Brittian; Sumanth D Prabhu; Mariusz Z Ratajczak; Gregg Rokosh
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

9.  Classification of genes and putative biomarker identification using distribution metrics on expression profiles.

Authors:  Hung-Chung Huang; Daniel Jupiter; Vincent VanBuren
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

10.  Proteolysis of human thrombin generates novel host defense peptides.

Authors:  Praveen Papareddy; Victoria Rydengård; Mukesh Pasupuleti; Björn Walse; Matthias Mörgelin; Anna Chalupka; Martin Malmsten; Artur Schmidtchen
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.